Status:
RECRUITING
Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Tourette Syndrome
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the occurrence of involuntary movements (motor tics) and vocalizations (phonic tics). The onset of TS is usually in chi...
Eligibility Criteria
Inclusion
- Patient at least 16 years old.
- Disabling and drug-resistant Tourette's syndrome.
- Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management.
- Normal brain MRI.
- Subject affiliated or beneficiary of a social security system.
- Free and informed consent of the patient and, for minors, of the minor and at least one parental authority.
Exclusion
- Major depressive syndrome (Beck Depression Inventory (BDI-II) \> 20).
- MRI showing significant brain atrophy or significant hyperintensities.
- Pregnant or nursing mothers.
- Person unable to give personal consent.
- Person subject to a legal protection measure (curatorship, guardianship) or placed under court protection.
- Patient included in another research protocol with an interdiction of participation to another research or in an exclusion period
Key Trial Info
Start Date :
February 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 17 2027
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06909656
Start Date
February 17 2025
End Date
February 17 2027
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France, 33076